ARTICLE | Company News
APT Therapeutics, AZ deal
January 20, 2017 7:32 PM UTC
The companies partnered to develop APT's APT102. APT will receive an upfront payment and is eligible for development milestones. AstraZeneca, which has an option to acquire the product, will fund tria...